4.7 Article

Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies

期刊

CLINICAL INFECTIOUS DISEASES
卷 72, 期 9, 页码 1657-1659

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciaa773

关键词

COVID-19; SARS-CoV-2; antimicrobial resistance; antibiotic resistance

向作者/读者索取更多资源

The COVID-19 pandemic and antimicrobial resistance are parallel health emergencies that provide the opportunity for mutual learning, with potential long-term impacts of AMR illustrated by the measures and consequences of COVID-19. There is a push to use existing antimicrobials for COVID-19 treatment, which may also impact the spread of AMR, highlighting the need for data collection to understand the influence of COVID-19 on AMR trends.
The coronavirus disease 2019 (COVID-19) pandemic and antimicrobial resistance (AMR) are parallel and interacting health emergencies that provide the opportunity for mutual learning. As their measures and consequences are comparable, the COVID-19 pandemic helps to illustrate the potential long-term impact of AMR, which is less acute but not less crucial. They may also impact each other as there is a push to use existing antimicrobials to treat critically ill COVID-19 patients in the absence of specific treatments. Attempts to manage the spread of COVID-19 may also lead to a slowdown in AMR. Understanding how COVID-19 affects AMR trends and what we can expect if these trends remain the same or worsen will help us to plan the next steps for tackling AMR. Researchers should start collecting data to measure the impact of current COVID-19 policies and programs on AMR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据